BiomeBurden™ Testing Series

Myco, Micro & Immune Evaluation

Go Beyond Presence. Detect the Immune Response.

BiomeBurden™ Complete reveals how the immune system is reacting to bacteria, fungi, and related toxins—delivering clinically actionable data that helps tailor targeted interventions for chronic gut, neuroimmune, and autoimmune cases.

Why BiomeBurden™ Matters

Goes Beyond Presence
Understand not just what's in the gut, but what's triggering immune activation.
Uncovers Hidden Drivers
Detect immune responses to bacterial and fungal antigens, toxins, and cross reactive proteins.
Supports Personalized Plans
Reveal immune imbalances that can guide treatment — from diet to immune modulation.

Ideal for patients with:

Persistant gut symptoms
(IBS, SIBO, dysbiosis)
Neuroinflammation
(brain fog, fatigue)
Autoimmune conditions
Unexplained chronic illness
The BiomeBurden™ testing series offers flexible options for evaluating microbial immune reactivity and immune regulation.

Each level adds more insight—starting with Candida reactivity, expanding to molds and bacteria, and culminating in full immune cell profiling.

Myco-BiomeBurden™

(Foundational)

  • Candida Albicans Antigens*
  • Candida Tropicalis + C. Glabrata*
  • Candida Parapsilosis + Krusei*
  • Candida Auris*
  • Candidalysin*
  • Candida Germ Tube Protein*
  • Alpha-Enolase*

Micro-BiomeBurden™

(Expanded)

  • Saccharomyces Cerevisiae Glucan*
  • Saccharomyces Boulardii*
  • Food-derived Molds*
  • Aerobic Enteropathogens*
  • Anaerobic Enteropathogens*
  • Neutrophil Activation Factors*
  • Actin Peptide*
  • Ubiquitin*

BiomeBurden™ Complete

(Comprehensive)

  • WBC
  • Total Lymphocyte
  • Total T-Cell
  • Th1
  • Th2
  • Th1/Th2 ratio
  • Th17
  • T-Reg
  • Th17/T-Reg ratio
* IgG and IgA tetsted speparatly

From Commensal to Pathogen

This visual outlines how Candida albicans shifts from a benign resident of the microbiome to an invasive organism capable of triggering immune activation. Understanding this transformation—and the immune response it provokes—can help identify when Candida is contributing to mucosal disruption or systemic burden.

How does the BiomeBurden™ Complete Compare?

Getting Started with BiomeBurden™

BiomeBurden™ testing requires just two tubes—one whole blood and one serum—to yield clinically meaningful insights. This minimal draw enables a comprehensive view of the patient’s immune reactivity across microbial, fungal, and human tissue antigens.

Elevated antibodies to components of the microbiome, mycobiome, neutrophil activation markers, or self-antigens may reflect early immune dysregulation—often years before clinical symptoms emerge. These immune markers can provide critical clues in cases of unresolved inflammation, persistent GI symptoms, or suspected autoimmunity.

By identifying immune reactivity patterns early, providers can take a proactive approach—modulating immune balance, targeting microbial or environmental triggers, and supporting long-term resilience before overt disease manifests.

Contact Us

If you like to learn more about the
BiomeBurden™ Testing Series.
/form-thankyou

To Get Started

Cyrex Laboratories works with licensed healthcare professionals throughout the United States.
Create a healthcare professional account now!

If you're already a Cyrex Labs account holder, click here to log into your account to download additional materials.